Quick Answer
Curanex Pharmaceuticals Inc reported Total Assets of $11.58 million for fiscal year 2025.
Curanex Pharmaceuticals Inc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $11.58M | +2135.8% |
| 2024 | $517.9K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $14.48M | — | +1739.3% |
| June 30, 2025 | $787.2K | — | +52.0% |
| December 31, 2024 | $517.9K | — | — |
- Curanex Pharmaceuticals Inc showed an increase of +2135.8% in Total Assets compared to the prior fiscal year.
- Over the 2024–2025 period, Curanex Pharmaceuticals Inc’s total assets has grown by 2135.8% (from $517.9 thousand to $11.58 million).
- The most recent figure is from Curanex Pharmaceuticals Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: